Purchase Order 75N92B21P00006

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Partek, Incorporated for $16,290.00 on March 16, 2021, with an ultimate completion date of March 31, 2021. No set-aside applied. Place of performance is Wildwood, Missouri. The order procures Partek Flow, a bioinformatics analysis software platform for processing next-generation sequencing data from multiple research projects at NIAMS. The software has demonstrated measurable increases in...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Partek, Incorporated for $17,000 on November 3, 2020, for a 12-month software license renewal. The order, priced on a firm fixed-price basis, supports single-cell transcriptomics, cell-type identification and discovery, and next-generation sequencing applications. Performance is located in Wildwood, Missouri. The order completed on November 3, 2020.</p>

The Department of Health and Human Services' National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $17,400 firm fixed price purchase order to Partek, Inc. of Wildwood, Missouri. The contract is for unspecified products or services to be delivered between November 2023 and November 2024. As a component of the NIH focused on arthritis, musculoskeletal disorders, and dermatological research, this award will likely support the Institute's...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian federal agency, awarded a $24,800.00 firm fixed price purchase order to Illumina, Inc. for a floating concurrent license for the Partek Genomics Suite software. The award has a period of performance through November 14, 2025 and was made on a full and open competition basis with no set-aside requirements. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Illumina, Inc. for $70,330.32 on August 10, 2026, for renewal of a floating license Partek Flow software package. Work is performed in San Diego, California. The order carries a firm fixed price and an ultimate completion date of August 9, 2027. No set-aside was used.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Illumina, Inc. for $371,720 on December 9, 2022, for the NIAMS Laboratory Information Management System (LIMS), with an ultimate completion date of December 8, 2025. Work is performed in San Diego, California. The order carries firm fixed-price terms and no set-aside designation.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Nanostring Technologies, Inc. valued at $19,000 on October 28, 2020, with completion by November 3, 2020. No set-aside was used. The order is firm fixed price for commercial genomic analysis platforms, reagents, or related life science tools. Place of performance is Bethesda, Maryland.</p>

<p>The National Institutes of Health Office of Logistics and Acquisition Operations awarded a purchase order to Partek, Incorporated for three Partek Genomics Suite floating concurrent subscriptions valued at $357,883.00 on September 17, 2015. Place of performance is Wildwood, Missouri. The order is a firm fixed-price arrangement with no set-aside designation. The period of performance ran from September 21, 2020 through March 20, 2021, covering a six-month extension.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to ProteinSimple for $37,250 on September 28, 2020, for acquisition of an automated immunoassay system. Place of performance is Bethesda, Maryland. The order carries a fixed-price award-fee structure with an ultimate completion date of November 30, 2020. No set-aside designation applied to this acquisition.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency under the National Institutes of Health (NIH), awarded a $19,440 firm fixed-price purchase order to Workotter, Inc. for a project portfolio management (PPM) software tool. The software allows NIAMS' project leads and others to prioritize and track projects, and balance the demand and supply of project resources. This award, with a completion date of September 5, 2025, is Workotter's third...